Value proposition

Outsmarting Cancer.

Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities.

Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes.

Genialis is trusted by pharma and diagnostics partners, and together, we are transforming medicine through data.


Data Fusion, Machine Learning, Biomedical Data Analysis, Omics Data Integration, Precision Medicine, Software Development, Data Visualization, Gene Signature, and Predictive Biomarker